Ga. Comp. R. & Regs. r. 480-11-.08. Records and Reports.

GeorgiaRegulations

Ask Donna

How this section applies to your facts.

Rules and Regulations of the State of Georgia › Department 480 RULES OF GEORGIA STATE BOARD OF PHARMACY › Chapter 480-11 PHARMACEUTICAL COMPOUNDING. › Ga. Comp. R. & Regs. r. 480-11-.08

This text was captured on Sep 30, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

(1) Any procedures or other records required to be maintained in compliance with this

chapter shall be retained for the same period of time as required in chapter 480-10 of the

Board Rules for the retention of prescription files.

(2) All records required to be retained under this chapter or copies of such records, shall be

readily available for authorized inspection during the retention period at the establishment

where the activities described in such records occurred. These records or copies thereof

shall be subject to photocopying or other means of reproduction as part of any such

inspection.

(3) Records required under this chapter may be retained either as the original records or as

true copies, such as photocopies, microfilm, microfiche, electronic files or other accurate

reproductions of the original records. All records or reports must be producible

immediately if requested by the Board or an agent of the GDNA or within forty-eight (48)

hours if maintained in a central database.

(4) In addition to standard record and reporting requirements, the following records and

reports must be maintained for sterile pharmaceuticals:

(a) A policy and procedure manual, including policies and procedures for cytotoxic

and/or infectious waste, if applicable; and

(b) Lot numbers and expiration dates of all the components used in compounding

sterile prescription drug orders.

(c) This record-keeping requirement does not apply when FDA approved and labeled

sterile injectable drug products, produced by registered pharmaceutical

manufacturers, are reconstituted under conditions as allowed by USP 797, and

each such sterile drug product must be administered within 24 hours of being

reconstituted.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.

Ga. Comp. R. & Regs. r. 480-11-.08. Records and Reports. · Ga. Comp. R. & Regs. r. 480-11-.08 | Frix